Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
Demographics (1)
- SEX - Sex (phv00531573.v1.p1)
Disease Events (5)
- AFFECTION_STATUS - Case control status of the subject for bladder cancer; all subjects are bladder cancer patients. (phv00531577.v1.p1)
- IS_TUMOR - Tumor status (phv00531582.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00531587.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00531586.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00531588.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00531578.v1.p1)
Other (12)
- ANALYTE_TYPE - Analyte Type (phv00531581.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00531580.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00531572.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00531583.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00531584.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00531585.v1.p1)
- SAMPLE_ID - Sample ID (phv00531579.v1.p1)
- SAMPLE_ID - Sample ID (phv00531575.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00531589.v1.p1)
- SUBJECT_ID - Subject ID (phv00531571.v1.p1)
- SUBJECT_ID - Subject ID (phv00531576.v1.p1)
- SUBJECT_ID - Subject ID (phv00531574.v1.p1)